pargyline has been researched along with 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gaál, J; Kardos, V; Kollár, E; Pátfalusi, M; Patthy, M; Singer, J; Solti, M; Sziráki, I | 1 |
May, T | 1 |
1 review(s) available for pargyline and 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2'-methyl-MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamines; Animals; Corpus Striatum; Dopamine Antagonists; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotoxins; Pargyline; Rats; Rats, Inbred Strains; Selegiline | 1994 |
1 other study(ies) available for pargyline and 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
1-Methyl-4-phenylpyridinium (MPP+) binds with high affinity to a beta-carboline binding site located on monoamine oxidase type A in rat brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding, Competitive; Brain; Carbolines; Cerebral Cortex; Harmine; Male; Monoamine Oxidase; Pargyline; Pyridinium Compounds; Rats; Rats, Wistar | 1993 |